Chiome Bioscience Inc. (TYO:4583)
Japan flag Japan · Delayed Price · Currency is JPY
149.00
+1.00 (0.68%)
Jul 17, 2025, 1:41 PM JST

Chiome Bioscience Revenue

Chiome Bioscience had revenue of 138.70M JPY in the quarter ending March 31, 2025, with 6.98% growth. This brings the company's revenue in the last twelve months to 789.86M, up 22.90% year-over-year. In the year 2024, Chiome Bioscience had annual revenue of 780.81M with 14.41% growth.

Revenue (ttm)
789.86M
Revenue Growth
+22.90%
P/S Ratio
12.70
Revenue / Employee
14.90M
Employees
53
Market Cap
10.03B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024780.81M98.35M14.41%
Dec 31, 2023682.46M51.65M8.19%
Dec 31, 2022630.82M-82.12M-11.52%
Dec 31, 2021712.93M232.08M48.26%
Dec 31, 2020480.85M33.28M7.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Mar 31, 2012 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chugai Pharmaceutical1,222.12B
Takeda Pharmaceutical Company4,581.55B
Daiichi Sankyo Company1,886.26B
HOYA Corporation866.03B
Terumo1,036.17B
Otsuka Holdings2,393.18B
Astellas Pharma1,912.32B
Shionogi &438.27B
Revenue Rankings